Hiromachi, Japan

Seiji Mistui

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiji Mistui. Retrieved from https://idiyas.com/inventor/seiji-mistui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seiji Mitsui: Innovator in Mevalonolactone Derivatives

Introduction

Seiji Mitsui is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds for medical applications. His work focuses on mevalonolactone derivatives, which have potential therapeutic uses.

Latest Patents

Mitsui holds a patent for "Mevalonolactone derivatives and process for the preparation thereof." This invention involves novel mevalonolactone derivatives characterized by specific chemical structures. These compounds are particularly useful for the treatment of hyperlipidemia. The preparation process includes halo-lactonizing the corresponding gamma, delta-unsaturated carboxylic acid derivatives and optionally dehalogenating the resulting product.

Career Highlights

Seiji Mitsui is associated with Sankyo Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical chemistry. His innovative approach has led to the creation of compounds that address significant health issues.

Collaborations

Mitsui has collaborated with notable colleagues, including Akira Ogiso and Akira Indo. Their combined expertise has contributed to the successful development of new chemical compounds.

Conclusion

Seiji Mitsui's work in the field of mevalonolactone derivatives showcases his commitment to innovation in pharmaceutical chemistry. His contributions have the potential to impact the treatment of hyperlipidemia significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…